Aude Ouensanga is a Partner at Alira Health. She joined the firm’s Paris office in 2012 and has worked out of the Boston area headquarters since 2015. In that time, Aude has managed dozens of market access, commercial due diligence, corporate strategy, and M&A projects for U.S., EU, and Japan-based clients in MedTech and Pharma. She advises both start-ups and multi-billion dollar global corporations in their business development.
Aude is an investment manager for two of Alira Health Ventures’ incubated companies, Computational Life and FireFly Innovations, for which she also serves on the board.
Prior to joining Alira Health, Aude worked as an M&A Analyst at BNP Paribas Corporate & Investment Banking for the chemicals sector and as a Strategy Analyst at Novartis Pharma.
Aude graduated from French Grande Ecole EM Lyon Business School where she specialized in Finance and Strategy and is a registered investment banker in the US, holding FINRA Series 79 and 63 certifications.